Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.
- Prospective, observational international cohort study.
- Any hospital worldwide can participate (including hospitals that have not admitted
SARS-CoV-2 infected patients).
- All patients undergoing a surgical procedure in an operating theatre will be included.
All consecutive eligible patients should be included.
- 7-day data collection period, with follow-up at 30 days after surgery for each patient.
However, no changes should be made to normal patient care/ follow-up pathways
- Primary outcome is 30-day mortality.
- All collaborators will be included as PubMed-citable co-authors on resulting
publications.
Inclusion criteria
- Any operation (elective or emergency) done in an operating theatre by a surgeon.
- All surgical specialties including: acute care surgery, breast surgery, cardiac
surgery, colorectal surgery, general surgery, gynaecology, hepatobiliary surgery,
neurosurgery, obstetrics, oesophagogastric surgery, ophthalmology, oral and
maxillofacial surgery, orthopaedics, otolaryngology, paediatric surgery, plastic
surgery, thoracic surgery, transplant surgery, trauma surgery, urology, vascular
surgery.
- Day case surgery and inpatient surgery included.
- Any SARS-CoV-2 status (positive at any time, negative, not tested).
- All ages including children and adults.
Exclusion criteria:
Minor procedures (full list will be available in the protocol).
Aneel Bhangu, PhD
+44 (0) 121 3718121
aneel.bhangu@gmail.com
Dmitri Nepogodiev, Master
+44 (0) 121 3718121
D.Nepogodiev@bham.ac.uk